(Date:10/13/2008)...levels were lower than Alzheimer,s patients, healt...hDay News) -- Parkinson,s disease patients are mor...ts to have vitamin D deficiency, say researchers f...anta. , They compared vitamin D levels in 100 P...99 healthy people matched for age and other factor...
(Date:10/13/2008)...as a greater effect on women, study found , ... alcohol you drink, the more your brain shrinks, a... is that, if you drink a lot, you,re going to hurt...ofessor of neuroscience and experimental therapeut...lege of Medicine. "This is something we knew, but ...
(Date:10/13/2008)...Oct. 13, 2008 /PRNewswire/ -- The AMERIGROUP Found... the School for Children with,Hidden Intelligence ...aining program., SCHI is a state-approved, privat...capped, underprivileged children with special need...d alleviate the suffering of the,most vulnerable m...
(Date:10/13/2008)...xercises to Build and Maintain a Healthy Spine, P...to educate people,about spine health, Texas Back I... of these nine easy exercises coincides with Natio... Spine Health Day was established to bring attenti... effective means of reducing the,prevalence and se...
Breaking Medicine News(10 mins):Health News:Parkinson's Patients More Prone to Vitamin D Deficiency 2Health News:Excess Drinking Shrinks the Brain 2Health News:AMERIGROUP Foundation Supports the School for Children with Hidden Intelligence 2Health News:Texas Back Institute Announces 'Nine for Your Spine' for National Spine Health Day - October 16 2Health News:Texas Back Institute Announces 'Nine for Your Spine' for National Spine Health Day - October 16 3...ain in patients following surgeries has been effec...action therapy. Doctors at the Johns Hopkins Medi...s with images and sounds from nature and have succ... painful procedure called bronchoscopy, which invo...
...imary disabling ailments in the world has found a ...y, titled 'A double-blind randomised controlled tr...jects with arthritis,' revealed that scientists su... from painful arthritis in 36 per cent of the pati...
...12 to 30% of young children are affected by iron d... of the common problems in childhood leading on to...tanding and walking. Eight-month-old infants with ...ikely to have deformities of the motor system, acc...
...e globulin (ATG), a compound made from rabbit anti...ids in reducing rejection of transplanted organs w...ames Eason of the Ochsner Multi-Organ Transplant C...roid-free treatment of liver transplants, Dr. Easo...
Other Medicine News:Health News:ATG useful in transplant patients as substitute for steroids 2(Date:10/8/2008)...l Reduce Animal Use in Cosmetics and Chemicals Tes...ek Corp. today announced,that results of a recentl...h-up" validation study on MatTek,s EpiDerm in vitr...emonstrated the required sensitivity and,specifici...native to animal,testing for determining human ski...
(Date:10/8/2008)...b Program to be Discontinued and Headcount to be R...ts Portfolio Review; Zanolimumab Program to be Di...of Employees, COPEN...A/S (OMX: GEN),announced today that it is disconti...n addition, as a result of a portfolio review and,...
(Date:10/8/2008)... Confirm Potency of Poly-ICR as Vaccine Adjuvant, ...a Biopharmaceuticals,Corporation (TSX: NVN) today ...sing its proprietary Toll-like Receptor 3 agonist,...ccine Congress 2008 in Lyon, France.,Study results...vant,targeting the Toll-like Receptor 3 (TLR3) pat...
(Date:10/7/2008).... 7 /- Prometheus Laboratories Inc., ...d findings from its,development of PROMETHEUS(R) I...rritable bowel syndrome (IBS). The findings sugges...icular biomarkers in blood samples,between IBS and...markers,combined with a proprietary algorithm, le...
Breaking Medicine Technology:MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Blood Donations in U S Testing Positive for Chagas Disease 1389 1Blood Donations in U S Testing Positive for Chagas Disease 1389 2Blood Donations in U S Testing Positive for Chagas Disease 1389 3Blood Donations in U S Testing Positive for Chagas Disease 1389 4American Diabetes Association Steps Up to Fight Diabetes 4208 1American Diabetes Association Steps Up to Fight Diabetes 4208 2American Diabetes Association Steps Up to Fight Diabetes 4208 3Fenwal Signs Development Distribution and Licensing Agreement With Data Innovations Inc 4206 1Fenwal Signs Development Distribution and Licensing Agreement With Data Innovations Inc 4206 2Fall Time Change Could Be Boon for Sleep 4204 1Fall Time Change Could Be Boon for Sleep 4204 2...05, 2007 /PRNewswire-FirstCall/ --,Nuvelo, Inc. to...inical study of novel monoclonal antibodies agains...rate that NTB-A is a,potential new target for immu...a and lymphomas. The study, entitled "The lymphoid...ntibody target for,leukemia and lymphoma therapeut...
...S WIRE)--Jun 5, 2007 - NovaDel Pharma,Inc. (AMEX: ...g,oral spray formulations for a broad range of mar...nical studies comparing zolpidem,oral spray with z...etic (PK), pharmacodynamic (PD) and safety objecti...bien(R), a leading,drug for the treatment of insom...
Other Medicine Technology:Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 2Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 3Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 4NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 2NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 3NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 4NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 5NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 6NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 7The Focus Diagnostics Rickettsia Indirect Immunofluorescence Antibody (IFA) IgM test is intended for the detection and semi-quantitation of human IgM class antibodies to Spotted Fever and Typhus Feve
...est Kits for the detection and semi-quantitation o... burnetii. Our dual antigen-spot slide wells allow...differentiation of antibodies to C. burnetii Phase...ses, Focus Diagnostics' Q Fever IFA Test Kits can ...
Indirect immunofluorescent antibody (IFA) test for the detection and semi-quantitation of human serum IgG antibodies to Epstein-Barr viral capsid antigen (VCA). Each kit contains ten 12-well slides,
CMF OL1000 Bone Growth Stimulators are portable, battery-powered medical devices indicated for use in the noninvasive treatment of an established nonunion fracture acquired secondary to trauma, exclu
Medicine Products: